346 related articles for article (PubMed ID: 24597646)
1. AlzPlatform: an Alzheimer's disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research.
Liu H; Wang L; Lv M; Pei R; Li P; Pei Z; Wang Y; Su W; Xie XQ
J Chem Inf Model; 2014 Apr; 54(4):1050-60. PubMed ID: 24597646
[TBL] [Abstract][Full Text] [Related]
2. StemCellCKB: An Integrated Stem Cell-Specific Chemogenomics KnowledgeBase for Target Identification and Systems-Pharmacology Research.
Zhang Y; Wang L; Feng Z; Cheng H; McGuire TF; Ding Y; Cheng T; Gao Y; Xie XQ
J Chem Inf Model; 2016 Oct; 56(10):1995-2004. PubMed ID: 27643925
[TBL] [Abstract][Full Text] [Related]
3. Pain-CKB, A Pain-Domain-Specific Chemogenomics Knowledgebase for Target Identification and Systems Pharmacology Research.
Feng Z; Chen M; Shen M; Liang T; Chen H; Xie XQ
J Chem Inf Model; 2020 Oct; 60(10):4429-4435. PubMed ID: 32786694
[TBL] [Abstract][Full Text] [Related]
4. Pain Chemogenomics Knowledgebase (Pain-CKB) for Systems Pharmacology Target Mapping and Physiologically Based Pharmacokinetic Modeling Investigation of Opioid Drug-Drug Interactions.
Shen M; Chen M; Liang T; Wang S; Xue Y; Bertz R; Xie XQ; Feng Z
ACS Chem Neurosci; 2020 Oct; 11(20):3245-3258. PubMed ID: 32966035
[TBL] [Abstract][Full Text] [Related]
5. GCDB: a glaucomatous chemogenomics database for in silico drug discovery.
Wei Y; Li J; Li B; Ma C; Xu X; Wang X; Liu A; Du T; Wang Z; Hong Z; Lin J
Database (Oxford); 2018 Jan; 2018():. PubMed ID: 30371760
[TBL] [Abstract][Full Text] [Related]
6. Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study.
Xu X; Ma S; Feng Z; Hu G; Wang L; Xie XQ
J Mol Graph Model; 2016 Nov; 70():284-295. PubMed ID: 27810775
[TBL] [Abstract][Full Text] [Related]
7. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database.
Wang L; Ma C; Wipf P; Liu H; Su W; Xie XQ
AAPS J; 2013 Apr; 15(2):395-406. PubMed ID: 23292636
[TBL] [Abstract][Full Text] [Related]
8. Virus-CKB: an integrated bioinformatics platform and analysis resource for COVID-19 research.
Feng Z; Chen M; Liang T; Shen M; Chen H; Xie XQ
Brief Bioinform; 2021 Mar; 22(2):882-895. PubMed ID: 32715315
[TBL] [Abstract][Full Text] [Related]
9. Progress in the development of new drugs in Alzheimer's disease.
Piau A; Nourhashémi F; Hein C; Caillaud C; Vellas B
J Nutr Health Aging; 2011 Jan; 15(1):45-57. PubMed ID: 21267520
[TBL] [Abstract][Full Text] [Related]
10. Virus-CKB 2.0: Viral-Associated Disease-Specific Chemogenomics Knowledgebase.
Hao Y; Chen M; Othman Y; Xie XQ; Feng Z
ACS Omega; 2022 Oct; 7(42):37476-37484. PubMed ID: 36312370
[TBL] [Abstract][Full Text] [Related]
11. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
[TBL] [Abstract][Full Text] [Related]
12. Chemogenomics knowledgebased polypharmacology analyses of drug abuse related G-protein coupled receptors and their ligands.
Xie XQ; Wang L; Liu H; Ouyang Q; Fang C; Su W
Front Pharmacol; 2014; 5():3. PubMed ID: 24567719
[TBL] [Abstract][Full Text] [Related]
13. CADD Modeling of Multi-Target Drugs Against Alzheimer's Disease.
Ambure P; Roy K
Curr Drug Targets; 2017; 18(5):522-533. PubMed ID: 26343117
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease.
Schaduangrat N; Prachayasittikul V; Choomwattana S; Wongchitrat P; Phopin K; Suwanjang W; Malik AA; Vincent B; Nantasenamat C
Med Res Rev; 2019 Sep; 39(5):1730-1778. PubMed ID: 30628099
[TBL] [Abstract][Full Text] [Related]
15. Machine learning identifies candidates for drug repurposing in Alzheimer's disease.
Rodriguez S; Hug C; Todorov P; Moret N; Boswell SA; Evans K; Zhou G; Johnson NT; Hyman BT; Sorger PK; Albers MW; Sokolov A
Nat Commun; 2021 Feb; 12(1):1033. PubMed ID: 33589615
[TBL] [Abstract][Full Text] [Related]
16. Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.
Wang T; Liu XH; Guan J; Ge S; Wu MB; Lin JP; Yang LR
Eur J Med Chem; 2019 May; 169():200-223. PubMed ID: 30884327
[TBL] [Abstract][Full Text] [Related]
17. Methodologies Related to Computational Models in View of Developing Anti-Alzheimer Drugs: An Overview.
Baheti K; Kale M
Curr Drug Discov Technol; 2019; 16(1):66-73. PubMed ID: 29663890
[TBL] [Abstract][Full Text] [Related]
18. New approaches for the treatment of Alzheimer's disease.
Fish PV; Steadman D; Bayle ED; Whiting P
Bioorg Med Chem Lett; 2019 Jan; 29(2):125-133. PubMed ID: 30501965
[TBL] [Abstract][Full Text] [Related]
19. Discovery of multitarget-directed ligands against Alzheimer's disease through systematic prediction of chemical-protein interactions.
Fang J; Li Y; Liu R; Pang X; Li C; Yang R; He Y; Lian W; Liu AL; Du GH
J Chem Inf Model; 2015 Jan; 55(1):149-64. PubMed ID: 25531792
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present).
Wang N; Qiu P; Cui W; Yan X; Zhang B; He S
Curr Med Chem; 2019; 26(30):5684-5710. PubMed ID: 30501591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
